Maggie Chon U Cheang

11PUBLICATIONS
97CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 12, 2026
Addition of chemotherapy to radiotherapy promotes progenitor-exhausted CD8⁺ T-cell clonal dominance in head and neck cancer.

|Sep 02, 2026
Why early pathology input matters in biologically rich cancer trials.

|Aug 13, 2023
Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727).

Holly Tovey, Orsolya Sipos, Joel S Parker

|Sep 26, 2022
Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast Cancers.

Patrycja Gazinska, Charlotte Milton, Jacopo Iacovacci

|Dec 30, 2021
Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor-positive Breast Cancers.

Milana A Bergamino, Gabriele Morani, Joel Parker

|Oct 14, 2021
Biomarkers of Response and Resistance to Palbociclib Plus Letrozole in Patients With ER+/HER2- Breast Cancer.

Mitch Dowsett, Lucy Kilburn, Mothaffar F Rimawi

Pageof 2

Frequent Collaborators

3 joint publications

Richard Buus

2 joint publications

Ioannis Roxanis

2 joint publications

Alan Melcher

2 joint publications

Lucy Kilburn